Oyster Point Pharmaceuticals

Patent cliffs & loss of exclusivity

Ophthalmology Indications

Company

Legal NameOyster Point Pharma, Inc.
Company Operating StatusAcquired
Contact Page URLhttps://oysterpointrx.com/contact-us/
Crunchbase URLhttps://www.crunchbase.com/organization/oyster-point-pharmaceuticals
Full Address202 Carnegie Center, Suite 109 Princeton, NJ 08540, US
LinkedIn URLhttps://linkedin.com/company/oysterpointrx
Phone countryUS
Pitchbook URLhttps://pitchbook.com/profiles/company/181720-90

1 upcoming patent cliff

DrugIngredientTypeCliff
  1. TYRVAYAVARENICLINE TARTRATESmall mol.Oct 2035

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.